Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma

British Journal of Surgery

Volumn 83, Issue 4, 1996, Pages 509-512

  Hill, S ^a   Meirion Thomas, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SKIN METASTASIS; SURGICAL TECHNIQUE; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LASER SURGERY; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WOUND HEALING;

EID: 9244224085     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830425     Document Type: Article

References (21)

1. Hill GJ, Hill HZ, Blumereich M. In: Schwartz RA, ed. Skin Cancer. Recognition and Management. New York: Springer, 1988.
2. Creech OJ, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958; 148: 616-32.
3. Stehlin JS Jr. Hyperthermic perfusion with chemotherapy for cancer of the extremities. Surg Gynecol Obstet 1969; 129: 305-8.
4. Krementz ET, Carrier PD, Sutherland CM, Campbell M. The use of regional chemotherapy in the management of malignant melanoma. World J Surg 1979; 3: 289-304.
5. Krementz EI, Ryan RF. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience. Ann Surg 1972; 175: 908-17.
6. Lejeune FD, Lienard D, ei Douaihy M, Sayedi JV, Ewalenko P. Results of 206 isolated limb perfusions for malignant melanoma. Eur J Surg Oncol 1989; 15: 510-19.
7. Skene AI, Bulman AS, Williams TR, Thomas JM, Westbury G. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. Br J Surg 1990; 77: 765-7.
8. Bulman AS, Jamieson CW. Isolated limb perfusion wich melphalan in the treatment of malignant melanoma. Br J Surg 1980; 67: 660-2.
9. Hill S, Thomas JM. Treatment of cutaneous metastases from malignant melanoma using the carbon-dioxide laser. Eur J Surg Oncol 1993; 19: 173-7.
10. Cavaliere R, Cavaliere F, Deraco M et al. Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences, Melanoma Research 1994; 4(Suppl 1): 5-11.
11. Krementz ET, Muchmore JH, Carter RD, Sutheriand CM. Multiple perfusions for melanoma. Melanoma Research 1994; 4(Suppl 1): 39-44.
12. Rosin DR. Isolated limb perfusion: past experience and present studies using a minimal-access approach. Melanoma Research 1994; 4(Suppl 1): 51-5.
13. Krementz ET, Ryan RF, Carter RD, Sutherland CM, Reed RJ. Hyperthermic regional perfusion for melanoma of the limbs. In: Balch CM, Milton G, eds. Cutaneous Melanoma. Philadelphia, Pennsylvania: Lippincott, 1989: 172-95.
14. Shiu MH, Knapper WH, Fortner JG et al. Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard). J Clin Oncol 1986; 4: 1819-26.
15. Di Fillippo F, Calabro A, Giannovelli D et al. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer 1989; 63: 2551-61.
16. Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF. Results for hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 1975; 140: 339-48.
17. Martijn H, Oldhoff J, Schraffordt-Koops H. Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs. Eur J Cancer 1981; 17: 471-6.
18. Ghussen F, Nagel K, Groth W, Miller JM, Stutzer H. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg 1984; 200: 764-8.
19. Cumberlin R, De Moss E, Lassus M, Friedman M. Isolation perfusion for malignant melanoma of the extremity: a review. J Clin Oncol 1985; 3: 1022-31.
20. Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High-dose recombinant tumour necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992; 10: 52-60.
21. Hill S, Fawcett WJ, Sheldon J, Soni N, Williams T, Thomas JM. Low-dose tumour necrosis factor α and melphalan in hyperthermic isolated limb perfusion. Br J Surg 1993; 80: 995-7.